Computer models provide new understanding of sickle cell disease

July 28, 2017

PROVIDENCE, R.I. [Brown University] -- Computer models developed by Brown University mathematicians show new details of what happens inside a red blood cell affected by sickle cell disease. The researchers said they hope their models, described in an article in the Biophysical Journal, will help in assessing drug strategies to combat the genetic blood disorder, which affects millions of people worldwide.

Sickle cell disease affects hemoglobin, molecules within red blood cells responsible for transporting oxygen. In normal red blood cells, hemoglobin is dispersed evenly throughout the cell. In sickle red blood cells, mutated hemoglobin can polymerize when deprived of oxygen, assembling themselves into long polymer fibers that push against the membranes of the cells, forcing them out of shape. The stiff, ill-shaped cells can become lodged in small capillaries throughout the body, leading to painful episodes known as sickle cell crisis.

"The goal of our work is to model both how these sickle hemoglobin fibers form as well as the mechanical properties of those fibers," said Lu Lu, a Ph.D. student in Brown Division of Applied Mathematics and the study's lead author. "There had been separate models for each of these things individually developed by us, but this brings those together into one comprehensive model."

The model uses detailed biomechanical data on how sickle hemoglobin molecules behave and bind with each other to simulate the assembly of a polymer fiber. Prior to this work, the problem had been that as the fiber grows, so does the amount of data the model must crunch. Modeling an entire polymer fiber at cellular scale using the details of each molecule was simply too computationally expensive.

"Even the world's fastest supercomputers wouldn't be able to handle it," said George Karniadakis, professor of applied math at Brown and the paper's senior author. "There's just too much happening and no way to capture it all computationally. That's what we were able to overcome with this work."

The researchers' solution was to apply what they call a mesoscopic adaptive resolution scheme or MARS. The MARS model calculates the detailed dynamics of each individual hemoglobin molecule only at the each end of polymer fibers, where new molecules are being recruited into the fiber. Once four layers of a fiber have been established, the model automatically dials back the resolution at which it represents that section. The model retains the important information about how the fiber behaves mechanically, but glosses over the fine details of each constituent molecule.

"By eliminating the fine details where we don't need them, we develop a model that can simulate this whole process and its effects on a red blood cell," Karniadakis said.

Using the new MARS simulations, the researchers were able to show how different configurations of growing polymer fibers are able to produce cells with different shapes. Though the disease gets its name because it causes many red blood cells take on a sickle-like shape, there are actually a variety of abnormal cell shapes present. This new modeling approach showed new details about how different fiber structures inside the cell produce different cell shapes.

"We are able to produce a polymerization profile for each of the cell types associated with the disease," Karniadakis said. "Now the goal is to use these models to look for ways of preventing the disease onset."

There is only one drug on the market that has been approved by the FDA for treating sickle cell, Karniadakis says. That drug, called hydroxyurea, is thought to work by boosting the amount of fetal hemoglobin -- the kind of hemoglobin that babies are born with -- in a patient's blood. Fetal hemoglobin is resistant to polymerization and, when present in sufficient quantity, is thought to disrupt the polymerization of sickle cell hemoglobin.

Using these new models, Karniadakis and his colleagues can now run simulations that include fetal hemoglobin. Those simulations could help to confirm that fetal hemoglobin does indeed disrupt polymerization, as well as help to establish how much fetal hemoglobin is necessary. That could help in establishing better dosage guidelines or in developing new and more effective drugs, the researchers say.

"The models give us a way to do preliminary testing on new approaches to stopping this disease," Karniadakis said. "Now that we can simulate the entire polymerization process, we think the models will be much more useful."
-end-
Lu and Karniadakis' co-authors on the paper were He Li, Xin Bian and Xuejin Li, all from Brown's Division of Applied Mathematics. The work was supported by the National Institutes of Health (U01HL114476). Computer time and other resources were provided under grants from the Department of Energy (DE-AC02-06CH11357, DE-AC05-00OR22725).

Brown University

Related Red Blood Cells Articles from Brightsurf:

SMART researchers develop fast and efficient method to produce red blood cells
Researchers from Singapore-MIT developed a faster and more efficient way to manufacture red blood cells that cuts down on cell culture time by half.

Synthetic red blood cells mimic natural ones, and have new abilities
Scientists have tried to develop synthetic red blood cells that mimic the favorable properties of natural ones, such as flexibility, oxygen transport and long circulation times.

Exeter student leads research concluding that small red blood cells could indicate cancer
Having abnormally small red blood cells - a condition known as microcytosis - could indicate cancer, according to new research led by a University of Exeter student working with a world-leading team.

Physicists design 'super-human' red blood cells to deliver drugs to specific targets
A team of physicists from McMaster University has developed a process to modify red blood cells so they can be used to distribute drugs throughout the body, which could specifically target infections or treat catastrophic diseases such as cancer or Alzheimer's.

Blood transfusions: Fresh red blood cells no better than older ones
Findings from the ABC-PICU study on critically ill children may alter policies at hospitals where fresh red cells are preferentially used.

Fresh red blood cell transfusions do not help critically ill children more than older cells
Researchers have found that transfusions using fresh red blood cells -- cells that have spent seven days or less in storage -- are no more beneficial than older red blood cells in reducing the risk of organ failure or death in critically ill children.

Red blood cell donor pregnancy history not tied to mortality after transfusion
A new study has found that the sex or pregnancy history of red blood cell donors does not influence the risk of death among patients who receive their blood.

How sickled red blood cells stick to blood vessels
An MIT study describes how sickled red blood cells get stuck in tiny blood vessels of patients with sickle-cell disease.

Novel gene in red blood cells may help adult newts regenerate limbs
Adult newts can repeatedly regenerate body parts. Researchers from Japan, including the University of Tsukuba, and the University of Daytona, have identified Newtic1, a gene that is expressed in clumps of red blood cells in the circulating blood.

Healthy red blood cells owe their shape to muscle-like structures
The findings could shed light on sickle cell diseases and other disorders where red blood cells are deformed.

Read More: Red Blood Cells News and Red Blood Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.